National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

HARDBACK
price:$49.95
add to cart

Rights & Permissions

topleft topright

Kidney Failure and the Federal Government (1991)
Institute of Medicine (IOM)

Citation Manager

. "Reimbusement Effects on Quality." Kidney Failure and the Federal Government. Washington, DC: The National Academies Press, 1991.

Please select a format:

BibTeX EndNote RefMan


Page
235
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Kidney Failure and the Federal Government

tration. Letter of March 15, 1990, to Saulo Klahr, M.D., President, National Kidney Foundation.

Oreopolis DG, Robson M, Isatt S, Clayton S, De Veber GA. 1978. A simple and safe technique for continuous ambulatory peritoneal dialysis (CAPD). Trans Am Soc Artif Intern Organs 24.478.


Pollack VE, Pesce A. 1990. Analysis of data related to the 1976–1989 patient population: Treatment characteristics and patient outcomes. Report to the Institute of Medicine. Cincinnati: Dialysis Clinic, Inc.-Cincinnati.

Popovich RP, Moncrief JW, Nolph KD, et al. 1978. Continuous ambulatory peritoneal dialysis. Ann Intern Med 88:449.


Rogers WH, Draper D, Kahn KL, et al. 1990. Quality of care before and after implementation of the DRG-based Prospective Payment System. JAMA 264:1989–1994.

Romeo AA. 1984. The Hemodialysis Equipment and Disposables Industry. OTA-HCS-32. Washington, D.C.: Office of Technology Assessment.

Rubenstein LV, Kahn KL, Reinisch EJ, et al. 1990. Changes in quality of care for five disease measured by implicit review, 1981 to 1986. JAMA 264:1974–1979.


Sargent JA. 1990. Shortfalls in the delivery of dialysis. Am J Kidney Dis 15:500–510.

Smith, Wayne, Director, Office of Survey and Certification, Health Standards and Quality Bureau, Health Care Financing Administration. Letter of August 3, 1989, to Dolph R. Chianchiano, Associate Director, National Kidney Foundation.


Tenckhoff H, Schecter H. 1968. A bacteriologically safe peritoneal access device. Trans Am Soc Artif Intern Organs 14:181–183.

Page
235
Front Matter (R1-R14)
Part I: Overview, Summary (1-22)
Introduction (23-36)
Part II: Patients and Providers, Perspectives of ESRD Patients (37-50)
Ethical Issues (51-61)
The Patient Population (62-84)
The ESRD Patient Population: Special Groups (85-109)
Structure of the Provider Community (110-132)
Part III: Access, Access Problems of ESRD Patients (133-166)
Access to Kidney Transplantation (167-188)
Part IV: Reimbursement and Quality, Medicare ESRD Payment Policy (189-211)
Reimbusement Effects on Quality (212-235)
Outpatient Dialysis Reimbursement Issues (236-273)
Quality Assessment and Assurance (274-312)
Part V: Data and Research, Data Systems (313-327)
Research Needs (328-334)
Appendix A: Glossary (335-346)
Appendix B: Acronyms and Initialisms (347-350)
Appendix C: Commissioned Papers and Contractor Reports (351-352)
Appendix D: Survival Analysis Methods for the End-Stage Renal Disease (ESRD) Program of Medicare (353-400)
Appendix E: Institute of Medicine ESRD Study Committee Public Hearing, May 5, 1989, Chicago, Illinois (401-402)
Appendix F: Institute of Medicine ESRD Study Committee Public Hearing on (403-404)
Appendix G: Institute of Medicine ESRD Study Committee Workshop on ESRD Staffing, November 3, 1989, Washington, D.C. (405-405)
Appendix H: Institute of Medicine ESRD Study Committee Workshop on Kidney Transplantation, December 13, 1989, Washington, D.C. (406-407)
Appendix I: Institute of Medicine ESRD Study Committee Workshop on Black and Other Nonwhite ESRD Patients, May 15, 1990, Washington, D.C. (408-408)
Appendix J: Institute of Medicine ESRD Study Committee ESRD Patient Focus-Group Participants (409-410)
Index (411-426)